BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11037982)

  • 1. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
    Mason LH
    J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure/function relationship of activating Ly-49D and inhibitory Ly-49G2 NK receptors.
    Ortaldo JR; Winkler-Pickett R; Willette-Brown J; Wange RL; Anderson SK; Palumbo GJ; Mason LH; McVicar DW
    J Immunol; 1999 Nov; 163(10):5269-77. PubMed ID: 10553049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion.
    Mason LH; Willette-Brown J; Mason AT; McVicar D; Ortaldo JR
    J Immunol; 2000 Jan; 164(2):603-11. PubMed ID: 10623801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope mapping of Ly-49G and G-like receptors: CK-1 antibody defines a polymorphic site of functional interaction with class I ligand.
    Osman MS; Silver ET; Varghese JC; Chang CS; Gong DE; Audette GF; Hazes B; Kane KP
    J Leukoc Biol; 2005 May; 77(5):644-51. PubMed ID: 15703200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A "chimeric" C57l-derived Ly49 inhibitory receptor resembling the Ly49D activation receptor.
    Mehta IK; Smith HR; Wang J; Margulies DH; Yokoyama WM
    Cell Immunol; 2001 Apr; 209(1):29-41. PubMed ID: 11414734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activating Ly-49D NK receptors: expression and function in relation to ontogeny and Ly-49 inhibitor receptors.
    Ortaldo JR; Winkler-Pickett R; Wiegand G
    J Leukoc Biol; 2000 Nov; 68(5):748-56. PubMed ID: 11073116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors.
    Smith KM; Wu J; Bakker AB; Phillips JH; Lanier LL
    J Immunol; 1998 Jul; 161(1):7-10. PubMed ID: 9647200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ligand for the murine NK activation receptor Ly-49D: activation of tolerized NK cells from beta 2-microglobulin-deficient mice.
    Furukawa H; Iizuka K; Poursine-Laurent J; Shastri N; Yokoyama WM
    J Immunol; 2002 Jul; 169(1):126-36. PubMed ID: 12077237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NK cell receptor calibration: effects of MHC class I induction on killing by Ly49Ahigh and Ly49Alow NK cells.
    Olsson-Alheim MY; Salcedo M; Ljunggren HG; Kärre K; Sentman CL
    J Immunol; 1997 Oct; 159(7):3189-94. PubMed ID: 9317116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
    Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
    Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase.
    Mason LH; Gosselin P; Anderson SK; Fogler WE; Ortaldo JR; McVicar DW
    J Immunol; 1997 Nov; 159(9):4187-96. PubMed ID: 9379012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.